Landmark trial
A Randomized Phase 2 Study Comparing 2 Stereotactic Body Radiation Therapy Schedules for Medically Inoperable Patients With Stage I Peripheral Non-Small Cell Lung Cancer: NRG Oncology RTOG 0915 (NCCTG N0927)
Videtic GMM, Hu C, Singh AK, et al. · NRG Oncology / RTOG
DoseLab summary
Randomized phase 2 comparison of a single-fraction and a multi-fraction SBRT schedule for peripheral stage I non-small cell lung cancer. An erratum and a long-term follow-up report were also published.
Why this is useful
Key trial behind single-fraction lung SBRT for peripheral tumors. Useful background when a single-fraction plan comes through.
Reference details
- Title
- A Randomized Phase 2 Study Comparing 2 Stereotactic Body Radiation Therapy Schedules for Medically Inoperable Patients With Stage I Peripheral Non-Small Cell Lung Cancer: NRG Oncology RTOG 0915 (NCCTG N0927)
- Authors / organization
- Videtic GMM, Hu C, Singh AK, et al. · NRG Oncology / RTOG
- Publication / protocol
- Int J Radiat Oncol Biol Phys. 2015;93(4):757–764
- Version
- Pending verification
- Year
- 2015
- DOI
- 10.1016/j.ijrobp.2015.07.2260
- Disease sites
- Lung
- Topics
- SBRT, Landmark trial, RTOG, NRG, Peripheral tumors, Single fraction
- Fractionation context
- SBRT (1 vs 4 fractions)
- Last reviewed by DoseLab
- Pending verification